Inventor
KASTELEIN ROBERT A
US62 patents
⚠️ This page may combine multiple inventors who share the name “KASTELEIN ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
31 patentsUS6756481B2Jun 29, 2004
IL-23 receptor binding compositions
SCHERING CORP103 citations98
US7422743B2Sep 9, 2008
Mammalian receptor protein DCRS5;methods of treatment
SCHERING CORP38 citations96
US7411041B2Aug 12, 2008
DCRS5 polypeptides
SCHERING CORP30 citations96
US7090847B1Aug 15, 2006
Mammalian cytokines; related reagents and methods
SCHERING CORP69 citations96
US6562578B1May 13, 2003
IL-17-like cytokine binding compounds and antibodies
SCHERING CORP63 citations96
US7183382B2Feb 27, 2007
Mammalian genes; related reagents and methods
SCHERING CORP50 citations94
US7887806B2Feb 15, 2011
Mammalian receptor proteins DCRS5; method of treatment
SCHERING CORP10 citations92
US7754214B2Jul 13, 2010
Mammalian receptor protein DCRS5; methods of treatment
SCHERING CORP14 citations92
US7749718B2Jul 6, 2010
Method for raising or isolating an antibody to DCRS5
SCHERING CORP11 citations92
US7740848B2Jun 22, 2010
Method of treatment of skin inflammation
SCHERING CORP15 citations92
US7510853B2Mar 31, 2009
Nucleic acids encoding DCRS5
SCHERING CORP10 citations92
US7501247B2Mar 10, 2009
Method of treating skin inflammation
SCHERING CORP31 citations92
US7427402B2Sep 23, 2008
Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
SCHERING CORP28 citations92
US6800460B1Oct 5, 2004
Mammalian cytokine complexes
SCHERING CORP38 citations92
US7071308B2Jul 4, 2006
Cytokine receptor
SCHERING CORP13 citations91
US6890734B2May 10, 2005
Nucleic acids encoding a cytokine receptor complex
SCHERING CORP16 citations91
US6326472B1Dec 4, 2001
Human receptor proteins; related reagents and methods
SCHERING CORP42 citations91
US7560530B1Jul 14, 2009
IL-33 receptor
SCHERING CORP20 citations90
US7271248B2Sep 18, 2007
Human receptor proteins; related reagents and methods
SCHERING CORP25 citations90
US7820168B2Oct 26, 2010
Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
SCHERING CORP16 citations83
US7883695B2Feb 8, 2011
IL-12P40 and IL-B30 polypeptide complex
SCHERING CORP12 citations82
US7655761B2Feb 2, 2010
IL-17-like cytokine binding compounds and antibodies
SCHERING CORP3 citations74
US7005501B2Feb 28, 2006
Purified mammalian cytokines; related reagents and methods
SCHERING CORP6 citations74
US7776540B2Aug 17, 2010
Method of treating skin inflammation
SCHERING CORP7 citations73
US7579440B2Aug 25, 2009
Mammalian cytokines; related reagents
SCHERING CORP5 citations72
US7569224B2Aug 4, 2009
Mammalian cytokines; receptors; related reagents and methods
SCHERING CORP5 citations72
US7148330B2Dec 12, 2006
Binding compounds for IL-27
SCHERING CORP5 citations72
US6843987B2Jan 18, 2005
Mammalian cytokines; receptors; related reagents and methods
SCHERING CORP8 citations72
US6225446B1May 1, 2001
Mutational variants of mammalian proteins
SCHERING CORP7 citations72
US5736390AApr 7, 1998
BCRF1 proteins as inhibitors of interferon-γ
SCHERING CORP1 citations63
US7670603B2Mar 2, 2010
Human DNAX toll-like receptor 4 proteins, related reagents and methods
SCHERING CORP3 citations60
MERCK SHARP & DOHME
10 patentsUS10544222B2Jan 28, 2020
PD1/CTLA4 binders
MERCK SHARP & DOHME22 citations93
US10501542B2Dec 10, 2019
CTLA4 binders
MERCK SHARP & DOHME16 citations93
US10323090B2Jun 18, 2019
PD1 and/or LAG3 binders
MERCK SHARP & DOHME26 citations93
US11155619B2Oct 26, 2021
PD1 and/or LAG3 binders
MERCK SHARP & DOHME4 citations83
US10751412B2Aug 25, 2020
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer
MERCK SHARP & DOHME6 citations80
US11168136B2Nov 9, 2021
PD1 and/or LAG3 binders
MERCK SHARP & DOHME2 citations72
US11168135B2Nov 9, 2021
PD1 and/or LAG3 binders
MERCK SHARP & DOHME2 citations72
US9970944B2May 15, 2018
Methods of modulating cytokine activity; related reagents
MERCK SHARP & DOHME5 citations71
US11052065B2Jul 6, 2021
Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist
MERCK SHARP & DOHME0 citations55
US8795666B2Aug 5, 2014
Antagonists of IL-23P19 for treatement of atopic dermatitis
MERCK SHARP & DOHME0 citations52
MERCK SHARP & DOHME LLC
3 patentsTIMANS JACQUELINE C
2 patentsCHACKERIAN ALISSA A
1 patentKASTELEIN ROBERT A
1 patentKOPF MANFRED
1 patentRECHE-GALLARDO PEDRO A
1 patentShowing the top 50 of 62 patents by PatentIndex Score.